Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)

NCT06745024 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT06745024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06745024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
May 7, 2025
Completion date
February 1, 2034
Enrollment
280 (estimated)
Sites
626

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the bone, metastatic malignant solid neoplasm